To evaluate whether metabolic changes in the primary tumour during and after preoperative radiochemotherapy (RCT) can predict the histopathological response in patients with locally advanced rectal cancer as well as disease-free survival (DFS) and overall survival (OS).
Leccisotti, L., Gambacorta, M. A., De Waure, C., Stefanelli, A., Barbaro, B., Vecchio, F. M., Coco, C., Persiani, R., Crucitti, A., Tortorelli, A., Giordano, A., Valentini, V., The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy, <<EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING>>, 2015; 42 (5): 657-666. [doi:10.1007/s00259-014-2820-9] [http://hdl.handle.net/10807/68411]
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy
Leccisotti, Lucia;Gambacorta, Maria Antonietta;De Waure, Chiara;Barbaro, Brunella;Vecchio, Fabio Maria;Coco, Claudio;Persiani, Roberto;Crucitti, Antonio;Giordano, Alessandro;Valentini, Vincenzo
2015
Abstract
To evaluate whether metabolic changes in the primary tumour during and after preoperative radiochemotherapy (RCT) can predict the histopathological response in patients with locally advanced rectal cancer as well as disease-free survival (DFS) and overall survival (OS).
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
